Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients With Recent Myocardial Infarction.

被引:0
|
作者
Inohara, Taku
Liang, Li
Kosinski, Andrzej
Smith, Eric E.
Schwamm, Lee H.
Hernandez, Adrian F.
Bhatt, Deepak L.
Fonarow, Gregg C.
Peterson, Eric D.
Xian, Ying
机构
关键词
Tissue plasminogen activator (tPA); Thrombolysis; Ischemic stroke; Stroke Emergency Cerebrovascular care; Myocardial infarction;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ATMP14
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Acute ischemic stroke: improving access to intravenous tissue plasminogen activator
    Turner, Ashby C.
    Schwamm, Lee H.
    Etherton, Mark R.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (05) : 277 - 287
  • [32] Safety and efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
    Rajapa, S.
    Sivakumar, S.
    Arjundas, D.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 133 - 133
  • [33] Intravenous Tissue Plasminogen Activator in Patients With Cocaine-Associated Acute Ischemic Stroke
    Martin-Schild, Sheryl
    Albright, Karen C.
    Misra, Vivek
    Philip, Maria
    Barreto, Andrew D.
    Hallevi, Hen
    Grotta, James C.
    Savitz, Sean I.
    STROKE, 2009, 40 (11) : 3635 - 3637
  • [34] Safety and Effectiveness of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in 80 Years and Older Acute Ischemic Stroke Patients
    Chen, Yan
    Li, Chen-hua
    Wang, Yu-Xin
    Zhang, Chen-Hao
    Dong, Zhong
    Zhang, Fang-fang
    Wang, Jin-Huan
    Zhang, Pei-Lan
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 72 (03) : 883 - 888
  • [35] Safety and Effectiveness of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in 80 Years and Older Acute Ischemic Stroke Patients
    Yan Chen
    Chen-hua Li
    Yu-Xin Wang
    Chen-Hao Zhang
    Zhong Dong
    Fang-fang Zhang
    Jin-Huan Wang
    Pei-Lan Zhang
    Cell Biochemistry and Biophysics, 2015, 72 : 883 - 888
  • [36] Serum Uric Acid Is Neuroprotective in Chinese Patients with Acute Ischemic Stroke Treated with Intravenous Recombinant Tissue Plasminogen Activator
    Liu, Xuan
    Liu, Ming
    Chen, Miao
    Ge, Qin-Min
    Pan, Shu-Ming
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (05): : 1080 - 1086
  • [37] Safety and effectiveness of intravenous thrombolysis with recombinant tissue plasminogen activator in eighty years and older acute ischemic stroke patients
    Chen, Y.
    Li, C. -H.
    Wang, Y. -X.
    Zhang, C. -H.
    Dong, Z.
    Zhang, F. -F.
    Wang, J. -H.
    Zhang, P. -L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (10) : 1852 - 1858
  • [38] Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
    Chapman, Sherita N.
    Mehndiratta, Prachi
    Johansen, Michelle C.
    McMurry, Timothy L.
    Johnston, Karen C.
    Southerland, Andrew M.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 75 - 87
  • [39] Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis in a Patient with Acute Ischemic Stroke Secondary to Aortic Dissection
    Hong, Keun-Sik
    Park, So-Young
    Whang, Seon-Il
    Seo, So-Young
    Lee, Dong-Ha
    Kim, Han-Joon
    Cho, Joong-Yang
    Cho, Yong-Jin
    Jang, Woo-Ik
    Kim, Chang Young
    JOURNAL OF CLINICAL NEUROLOGY, 2009, 5 (01): : 49 - 52
  • [40] Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator
    Betts, Keith A.
    Hurley, Dana
    Song, Jinlin
    Sajeev, Gautam
    Guo, Jenny
    Du, Ella Xiaoyan
    Paschoalin, Marco
    Wu, Eric Q.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (09): : 1996 - 2003